AZN

AstraZenecaF

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

25%

Probability

Target price

$123.69

-30.3% vs current

Most likely

Base case

60%

Probability

Target price

$97.65

-45.0% vs current

B-

Bear case

15%

Probability

Target price

$79.98

-54.9% vs current

AI sentiment snapshot

Latest data as of 2026-01-24

AI commentary

Consensus is mildly constructive with median targets near our base case; near-term focus is the FY2025 print, while longer-term sentiment hinges on late-stage pipeline outcomes.

RankAlpha Sentiment AI - 2026-01-24

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-02-10eventFY2025 earnings releaseMedium impact

Full-year 2025 results and guidance update; historically a primary re-pricing event for the stock.

2026-04-24catalystNear-term capital-allocation updateMedium impact

Potential buyback/dividend commentary or modest buyback tranche announcement that could support the share price.

2027-01-24catalystLate-stage trial readouts / regulatory milestonesHigh impact

Clinical or regulatory outcomes for late-stage assets that could drive material upside or downside over a longer horizon.

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-24 • Updated nightlySource: Internal modelMethodology